For prostate and other cancers it will have to go through clinical trials, but i can see them being able to bypass phase 1 and 2 as dose toxicity will have already been established.
Second; insurance won’t pay $100,000 a shot unless unless it matches the criteria of the clinical trial. This trial the article mentions said it is being tested on post operative patients before cancer has spread. That rules out any advanced cancer patients.
It is the same technology as the mRNA covid vaccine so i can only see it as a government expenditure just like Covid.
I am hoping they do the fast track for all cancers with this once the melanoma trial is done, and approved.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.